(Z)-7-[(1R,2R,3R,5S)-2-[(E,3S)-5-(4-bromo-5-methylthiophen-2-yl)-3-(oxan-2-yloxy)pent-1-enyl]-3,5-bis(oxan-2-yloxy)cyclopentyl]hept-5-enoic acid | 876054-15-8

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: (Z)-7-[(1R,2R,3R,5S)-2-[(E,3S)-5-(4-bromo-5-methylthiophen-2-yl)-3-(oxan-2-yloxy)pent-1-enyl]-3,5-bis(oxan-2-yloxy)cyclopentyl]hept-5-enoic acid
• CAS: 876054-15-8
• 化学式: C₃₇H₅₅BrO₈S
• 分子量: 739.809
• InChiKey: ZETXOXRYTWQPRP-FBSNQIRISA-N

计算性质

• 辛醇/水分配系数(LogP)：
  7.7
• 重原子数：
  47
• 可旋转键数：
  17
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.76
• 拓扑面积：
  121
• 氢给体数：
  1
• 氢受体数：
  9

反应信息

• 作为反应物：
  描述：

  (Z)-7-[(1R,2R,3R,5S)-2-[(E,3S)-5-(4-bromo-5-methylthiophen-2-yl)-3-(oxan-2-yloxy)pent-1-enyl]-3,5-bis(oxan-2-yloxy)cyclopentyl]hept-5-enoic acid 、 碘甲烷 在 1,8-二氮杂双环[5.4.0]十一碳-7-烯 作用下， 以 丙酮 为溶剂， 反应 21.0h， 生成 (Z)-7-[(1R,2R,3R,5S)-2-[(E)-(S)-5-(4-bromo-5-methyl-thiophen-2-yl)-3-(tetrahydro-pyran-2-yloxy)-pent-1-enyl]-3,5-bis-(tetrahydro-pyran-2-yloxy)-cyclopentyl]-hept-5-enoic acid methyl ester
  参考文献：
  名称：

  Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents

  摘要：

  一种化合物，包括或其药用可接受的盐或前药，其中A、B、R1、R2、D和E在此定义。用于治疗疾病的治疗方法，以及相关的组合物和药物也被披露。

  公开号：

  US20060035961A1

文献信息

• CYCLOPENTANE HEPTAN(ENE)OIC ACID, 2-HETEROARYLALKENYL DERIVATIVES AS THERAPEUTIC AGENTS
  申请人：Donde Yariv

  公开号：US20070112051A1

  公开（公告）日：2007-05-17

  A compound comprising or a pharmaceutically acceptable salt or a prodrug thereof, having the groups described in detail herein is disclosed. Also disclosed herein are compounds comprising or derivatives thereof, or pharmaceutically acceptable salts, tetrazoles, or prodrugs of compounds of the structure or derivatives thereof, said derivatives being described in detail herein. Also disclosed herein are methods of treating diseases or conditions, including glaucoma and elevated intraocular pressure. Compositions and methods of manufacturing medicaments related thereto are also disclosed.

  本文披露了一种含有所述详细描述的基团的化合物或其药学上可接受的盐或前药。本文还披露了包括所述衍生物或其药学上可接受的盐、四唑或所述衍生物的前药的化合物。所述衍生物在本文中有详细描述。本文还披露了治疗疾病或病症的方法，包括青光眼和眼压升高。还披露了相关药物的组成和制造方法。
• Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
  申请人：Donde Yariv

  公开号：US20060035960A1

  公开（公告）日：2006-02-16

  A compound comprising or a pharmaceutically acceptable salt or a prodrug thereof, having the groups described in detail herein is disclosed. Also disclosed herein are compounds comprising or derivatives thereof, or pharmaceutically acceptable salts, tetrazoles, or prodrugs of compounds of the structure or derivatives thereof, said derivatives being described in detail herein. Also disclosed herein are methods of treating diseases or conditions, including glaucoma and elevated intraocular pressure. Compositions and methods of manufacturing medicaments related thereto are also disclosed.

  本文披露了一种化合物，包括具有详细描述的基团或其药学上可接受的盐或前药。本文还披露了包括该化合物或其衍生物、药学上可接受的盐、四唑或该化合物或其衍生物的前药的化合物。其中，所述衍生物在本文中有详细描述。本文还披露了治疗疾病或病症的方法，包括青光眼和眼内压升高。同时还披露了相关药物的组成和制造方法。
• US8557860B2
  申请人：——

  公开号：US8557860B2

  公开（公告）日：2013-10-15